Relevant bibliographies by topics / Mastectomie – Patientes

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Mastectomie – Patientes'

Author: Grafiati
Published: 4 June 2021
Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mastectomie – Patientes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Mastectomie – Patientes"

1

Couillet, A., D. Mouttet, V. Bonadona, and J. Henry. "Comment répondre aux demandes de mastectomie prophylactique controlatérale après un cancer du sein hors prédisposition génétique ? Perspectives éthiques et cliniques." Psycho-Oncologie 13, no. 2 (2019): 129–35. http://dx.doi.org/10.3166/pson-2019-0097.

Full text
Abstract:
Les mastectomies prophylactiques controlatérales sont proposées aux patientes présentant une prédisposition génétique ou étant à haut risque familial. Elles augmentent en dehors de ces contextes, alorsmême que la procédure n’apporte pas de bénéfice sur le risque de récidive du cancer du sein. À une époque où l’on prône l’autonomie des patients, quelle place peut-on laisser à la responsabilité du soignant ? Nous verrons comment l’éthique et la clinique viennent mettre un cadre à une médecine devenue toute-puissante.
APA, Harvard, Vancouver, ISO, and other styles
2

Lobelle, S., M. Raylet, M. Cohen, et al. "Mastectomie en hospitalisation ambulatoire ou de 24 heures : faisabilité, satisfaction et préférences des patientes." Gynécologie Obstétrique Fertilité & Sénologie 45, no. 2 (2017): 89–94. http://dx.doi.org/10.1016/j.gofs.2016.12.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guillemin, F., F. Marchal, and M. Geffroy. "Évaluation d’un second traitement chirurgical conservateur pour récidive locale d’un cancer du sein." Oncologie 21, no. 1-4 (2019): 22–28. http://dx.doi.org/10.3166/onco-2019-0028.

Full text
Abstract:
Objectif : Évaluation d’un deuxième traitement conservateur (T) [n = 41] par rapport à une mastectomie totale (M) [n = 93]. Étude rétrospective unicentrique de 134 patientes ayant présenté une récidive mammaire homolatérale isolée et opérable. Résultats : La survie globale à cinq ans est de 82,5 % dans les deux groupes. Pas de différence significative pour la survie spécifique et la survie sans métastase dans les deux groupes. Le contrôle local à cinq ans est de 92,9 % dans le groupe Met de 66,2 % dans le groupe T (RR de nouvelle récidive de 4,48). La présence d’emboles, le caractère multifocal et la révélation clinique de la récidive sont des facteurs pronostiques péjoratifs de survie. Sur l’ensemble de la série (n = 134), 25 (18,6 %) ont conservé leur sein. Conclusion : Pour minimiser le risque de récidive après un second traitement conservateur, on peut envisager cette chirurgie si la récidive est isolée, de petite taille, de bas grade, sans embole, et strictement unifocale. L’acte chirurgical doit assurer des marges saines et un résultat esthétique satisfaisant. La patiente participe au choix du traitement.
APA, Harvard, Vancouver, ISO, and other styles
4

Barranger, E. "La mastectomie en ambulatoire ou en hospitalisation de 24 h : une alternative possible à l’hospitalisation complète pour certaines patientes." Gynécologie Obstétrique Fertilité & Sénologie 45, no. 2 (2017): 65–66. http://dx.doi.org/10.1016/j.gofs.2016.12.024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Klausner, G., J. F. Honart, N. Leymarie, et al. "Radiothérapie externe adjuvante après mastectomie et reconstruction mammaire immédiate par expandeur chez des patientes prises en charge pour un cancer du sein localisé." Cancer/Radiothérapie 22, no. 6-7 (2018): 716. http://dx.doi.org/10.1016/j.canrad.2018.07.063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Selz, J., S. Bruant, F. Coussy, B. de La Lande, A. Labib, and R. Le Scodan. "Rôle de l’irradiation après mastectomie chez les patientes atteintes d’un cancer du sein de stade II-III sans envahissement ganglionnaire après chimiothérapie néoadjuvante." Cancer/Radiothérapie 14, no. 6-7 (2010): 661. http://dx.doi.org/10.1016/j.canrad.2010.07.622.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marchal, C. "Réirradiation pariétale après mastectomie de rattrapage pour récidive sur sein conservé : étude rétrospective sur 31 patientes traitées à Nancy de 1988 à 2005." Cancer/Radiothérapie 12, no. 6-7 (2008): 719–20. http://dx.doi.org/10.1016/j.canrad.2008.08.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Racadot, S., C. Marchal, C. Charra-Brunaud, J. L. Verhaeghe, D. Peiffert, and P. Bey. "Ré-irradiation pariétale après mastectomie de rattrapage pour récidive d’un cancer du sein après traitement conservateur : étude rétrospective sur 20 patientes (Nancy : 1988–2001)." Cancer/Radiothérapie 7, no. 6 (2003): 369–79. http://dx.doi.org/10.1016/j.canrad.2003.07.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rat, F., C. Lemanski, C. Llacer Moscardo, et al. "Impact de la radiothérapie après mastectomie chez les patientes atteintes de cancer du sein à risque intermédiaire : résultat clinique à long terme du CRLC Val-d’Aurelle de Montpellier." Cancer/Radiothérapie 13, no. 6-7 (2009): 690–91. http://dx.doi.org/10.1016/j.canrad.2009.08.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ivanov, Olga, Nicole Centers, Karen Wiercinski, Eva Reina, Cynthia Buffington, and Aileen Caceres. "BRCA mutation carriers undergoing combined mastectomy with immediate reconstruction and gynecologic risk-reducing surgery: An analysis of outcomes." Journal of Clinical Oncology 35, no. 15_suppl (2017): e13004-e13004. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13004.

Full text
Abstract:
e13004 Background: The aim of this study was to assess outcomes of a multidisciplinary model for combined prophylactic and/or therapeutic mastectomy with immediate reconstruction and gynecologic risk-reducing surgery in patients with hereditary breast cancer syndromes. Methods: Between 2012 and 2016, 12 patients with documented BRCA1 and BRCA2 mutations underwent combined surgery at our facility. Procedures included bilateral mastectomy, axillary lymph node staging, immediate expander based reconstruction and minimally invasive salpingo-oophorectomy with added hysterectomy when indicated. All procedures were performed in a single operating room setting by rotating subspecialty teams. Results: Patient characteristics included a mean (+SD) BMI of 32.1±6.7 (23-44) kg/m2 and ASA of 2.2±0.4 (2-3). Fifty-eight percent (7/12) were premenopausal. Patient’s average age was 45.8+10.8 (30-73). Therapeutic mastectomy for breast cancer was performed in 4/12 patients. Of the 4 affected patients 2 had neo-adjuvant chemotherapy for locally advanced cancer. The remaining 8/12 had prophylactic mastectomies. Risk-reducing salpingo-oophorectomy was performed in 12/12 patients. Seventy-five percent (9/12) underwent concurrent minimally invasive hysterectomy for suspected gynecologic malignancy, leiomyoma, complex endometrial hyperplasia, dysmenorrhea and menorrhagia. Two gynecologic specimens required mini-laparotomy for removal. Mean total operative time was 283.3±66.5 (206-447) minutes and estimated blood loss (EBL) was 209.2±139.2 (50-500) ml. Hospital length of stay (LOS) was 1.4±0.7 (1-3) days. There were no significant differences (p > 0.05) in operative time, EBL, or LOS in comparing therapeutic to prophylactic mastectomies. Follow-up revealed no postoperative wound infections. Conclusions: Combined mastectomy with immediate reconstruction and gynecologic risk reducing surgery had no untoward surgical complications with a zero postoperative wound infection rate. Although a small study population, results indicate this approach is a prudent and feasible multidisciplinary model that can be offered to BRCA mutation carriers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Mastectomie – Patientes"

1

St-Pierre, Dominique. "Évaluation d'un accompagnement par les pairs à l'intention des femmes envisageant la mastectomie prophylactique." Master's thesis, Université Laval, 2017. http://hdl.handle.net/20.500.11794/27695.

Full text
Abstract:
La mastectomie prophylactique est une stratégie efficace, quoique controversée, visant à réduire le risque de cancer du sein chez les femmes porteuses d'une anomalie des gènes BRCA1/2. La décision de recourir à une mastectomie prophylactique est complexe et irréversible. Bien que cette chirurgie permette aux femmes de réduire considérablement leurs préoccupations face au cancer, elle peut néanmoins avoir divers impacts négatifs sur la qualité de vie, l'image de soi et la sexualité. Les femmes envisageant cette chirurgie expriment leur désir de discuter des implications de cette procédure avec des femmes y ayant déjà eu recours. Cette étude qualitative porte sur le développement et l'évaluation d'une intervention téléphonique d'aide par les pairs visant à 1) décrire les thèmes abordés lors d'une intervention de soutien téléphonique entre les bénéficiaires et les paires aidantes; et 2) explorer les perspectives des participantes concernant l'intervention. À l'aide d'un journal de bord et d'un questionnaire d'évaluation évaluant leur point de vue sur l'intervention, 13 jumelages ont été faits et les récits ont été analysés à l'aide d'une analyse thématique de contenu. Trois dimensions principales ont émergé: physique, psychologique et sociale. Les thèmes les plus fréquemment abordés ont été: chirurgie (92%), convalescence (77%), douleur et confort (69%), impact sur l'intimité et la sexualité (54%), anxiété reliée au cancer (54%), expérience reliée à la perte des seins (46%). Cette étude est la première à suggérer qu'une intervention téléphonique brève d'aide par les pairs permet de combler certains besoins exprimés par les femmes envisageant la mastectomie prophylactique. Tant pour les bénéficiaires que les paires aidantes, le partage de l'expérience de la mastectomie prophylactique ainsi que le soutien mutuel généré par la relation d'accompagnement ont contribué grandement à leur satisfaction vis-à-vis l'intervention. Une attention spéciale doit être portée sur la similarité des profils afin de créer des jumelages harmonieux.
APA, Harvard, Vancouver, ISO, and other styles
2

Dommesent, Damien. "Le cancer du sein inflammatoire : à propos de 40 patientes traitées au Centre François Baclesse entre 1987 et 1992." Caen, 1993. http://www.theses.fr/1993CAEN3072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Suzor, Carole. "Miroirs : l'identité et l'intimité sexuelle chez les femmes ayant vécu l'expérience de l'ablation d'un sein." Master's thesis, Université Laval, 2007. http://hdl.handle.net/20.500.11794/19952.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Poon, Yuet-fai Helena. "The psychological reactions of breast cancer patients with mastectomy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1996. http://hub.hku.hk/bib/B29697475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shatley, Joseph Andrew, and L. Lee Glenn. "Sexuality and Quality of Life of Breast Cancer Patients Post Mastectomy." Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/etsu-works/7510.

Full text
Abstract:
Excerpt: Manganiello et al., (2010) aimed to evaluate the sexual functioning of mastectomy patients and its association with their quality of life. There are two shortcomings with this study that render its conclusions invalid, or at least, weakly supported.
APA, Harvard, Vancouver, ISO, and other styles
6

Gahm, Jessica. "Bilateral prophylactic mastectomy and immediate breast reconstruction with implants." Stockholm : Section of Reconstructive Plastic Surgery, Karolinska Institutet, 2009. http://diss.kib.ki.se/2009/978-91-7409-704-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Elele, Tugba. "A Decision Analytic Model For Early Stage Breast Cancer Patients: Lumpectomy Vs Mastectomy." Master's thesis, METU, 2006. http://etd.lib.metu.edu.tr/upload/12607770/index.pdf.

Full text
Abstract:
The purpose of this study was to develop a decision model for early-stage breast cancer patients. This model provides an opportunity for comparing two main treatment options, mastectomy and lumpectomy, with respect to quality of life by making use of Decision Theoretic Techniques. A Markov chain was constructed to project the clinical history of breast carcinoma following surgery. Then, health states used in the model were characterized by transition probabilities and utilities for quality of life. A Multi Attribute Utility Model was developed for outcome evaluation. This study was performed on the sample population of female university students, and utilities were elicited from these healthy volunteers. The results yielded by Multi Attribute Utility Model were validated by using Von Neumann-Morgenstern Standard Gamble technique. Finally, Monte Carlo Simulation was utilized in Treeage-Pro 2006 Suit software program in order to solve model and calculate expected utility value generated by each treatment option. The results showed that lumpectomy is more favorable for people who participated in this study. Sensitivity analysis on transition probabilities to local recurrence and salvaged states was performed and two threshold values were observed. Additionally, sensitivity analysis on utilities showed that the model was more sensitive to no evidence of disease state
however, was not sensitive to utilities of local recurrence and salvaged states.
APA, Harvard, Vancouver, ISO, and other styles
8

Bergström, Madeleine. "Skin dose measurement during radiation therapy of mastectomy patients using GafChromicTM EBT3 films." Thesis, Linköpings universitet, Institutionen för medicinsk teknik, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-144289.

Full text
Abstract:
Purpose: The aim of this study was to develop a method of measuring changes in the skin microcirculation and skin dose for mastectomy patients in connection with the radiation treatment. The distribution of the skin dose, its dependence on the energy of the beam, field geometry and bolus material and the accuracy of the given skin dose in the treatment planning system were studied. Finally, the correlation between the given dose and the changes in skin microcirculation was evaluated. Methods: Skin dose was measured using GafChromic EBT3 films. To evaluate the impact of different energies and field geometry measurements on a PMMA phantom were done. Dose measurements were done using an anthropomorphic phantom and in patients. The measured skin doses were compered to the doses calculated using the treatment planning system. Before and after treatment, skin blood perfusion was measured using laser speckle contrast imaging. In connection with the last measurement also methyl nicotinate was used to increase the perfusion for the measurement. Results: The measurements on the PMMA-phantom indicate that a larger photon energy results in a lower dose to the skin, but a higher exit dose. Furthermore a more oblique angle results in a higher skin dose and a larger field size also results in an increased skin dose. The patient measurements showed that the skin dose was significantly different in different areas of the irradiated field. The highest dose was measured in the area in which a bolus was applied. All patients showed a significant increase in skin blood of the perfusion within the irradiated area. The comparison between the measured doses and the doses calculated using the treatment planning system shows an underestimation of the skin dose by the treatment planning system depending on the incident angle and the presence of bolus material. Conclusion: The distribution of the skin dose during breast cancer radiotherapy in mastectomy patients is heterogeneous with the highest dose in the area of the mastectomy scar, due to the presence of bolus material. A correlation can be noticed between the changed in microcirculation and the radiation dose to the skin. Estimation of the skin dose using the treatment planning system is inaccurate, but film doseimetry offers an easy-to use method to accurately measure the dose to different areas of the irradiated skin.
APA, Harvard, Vancouver, ISO, and other styles
9

Fabian, Tania, and Caroline Fredriksson. "Kvinnors beslutsfattande vid profylaktisk mastektomi : En litteraturstudie." Thesis, Högskolan i Halmstad, Akademin för hälsa och välfärd, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-41349.

Full text
Abstract:
Bakgrund: Profylaktisk mastektomi är en behandling där brösten avlägsnas kirurgiskt i förebyggande syfte. Det finns olika indikationer till att profylaktisk mastektomi övervägs. Begreppet beslutsfattande kräver förståelse för att kunna beskriva kvinnors beslut vid profylaktisk kirurgi med anledning av att den individuella osäkerheten kring behandlingsval ska minska. Information och stöd är viktiga aspekter för en sjuksköterska att ge för att främja patientens integritet, självbestämmande och delaktighet. Syftet med litteraturstudien var att beskriva faktorer relaterade till beslutsfattandet hos kvinnor vid profylaktisk mastektomi. Metoden som användes var en allmän litteraturstudie med induktiv ansats där tio vetenskapliga artiklar med anknytning till aktuellt syfte valdes ut för att utforma ett resultat. Resultatet utmynnade i tre olika kategorier varav en med två underkategorier och en med tre underkategorier. Oro, föräldraskap, genmutation och upplevelse av information visade sig influera beslutsfattandet. Få skillnader i beslutsfattandet påvisades mellan kvinnor som var bärare och ickebärare av genmutation. Konklusion: Kvinnor som stod inför ett beslutsfattande vid profylaktisk mastektomi var alla egna individer och hade därmed olika preferenser i avseende behov av stöd, delaktighet i beslutsfattandet, mottagandet av information samt vad som influerat beslutet. Vårdprofessionella ska presentera adekvat, evidensbaserad samt enhällig information för att underlätta kvinnors beslutfattande.
Background: Prophylactic mastectomy is a treatment where the breasts are surgically removed for preventive purposes. There are various indications why prophylactic mastectomy is being considered. Understanding the concept of decision making is required to describe women’s decision about prophylactic surgery in order to reduce individual uncertainty about treatment choices. Information and support are important aspects for a nurse to provide in order to encourage patient integrity, self-determination and participation. The aim of this literature study was to describe factors related to decision making among women regarding prophylactic mastectomy. The method was a literature study with an inductive approach. Ten scientific articles related to the current purpose were selected to form a result. The result emerged in to three different categories, one with two subcategories and one with three subcategories. Concerns, parenting, gene mutation and experience of information were found to influence the decision making. Few differences in decision making were detected between women who were carriers and non-carriers of gene mutation. Conclusion: Women who faced a decision making in prophylactic mastectomy were all individuals and there for had different preferences regarding need for support, participation in decision making, receiving information and what influenced the decision. Health care professionals should present adequat, evidence based and unanimous information to ease women’s decision making.
APA, Harvard, Vancouver, ISO, and other styles
10

Chouliara, Zoe. "Health beliefs and personality correlates of breast cancer : from screening to mastectomy adjustment : a cross-cultural study between Scotland and Greece." Thesis, University of Stirling, 2003. http://hdl.handle.net/1893/11899.

Full text
Abstract:
The present thesis consists of three thematic parts in relation to breast cancer: (a) practice of breast self - examination (BSE), (b) screening mammography attendance and (c) adjustment to breast cancer surgery / mastectomy. The aims of the respective studies are (a) to examine attitudes, beliefs and practices regarding BSE in younger (30 years old or under) and older women (over 30 years old), (b) to explore attitudes and beliefs regarding mammography and identify factors associated with screening mammography attendance and (c) to explore factors associated with adjustment to breast cancer surgery. The above aims are explored in two different cultural contexts, by comparing samples from Scotland and Greece. Samples consisted (a) of 205 younger and 258 older women, university staff and students in Scotland and 85 younger women, university students in Greece, (b) 283 women who attended and 72 women who did not attend the National Breast Screening in Scotland, and 72 women undergoing mammography in Greece and (c) 19 women in Scotland and 27 women in Greece, who have undergone surgery for breast cancer. All participants were assessed on a variety of measures. These included demographics, health history, health beliefs and health - related personality variables. Results indicated that: 1. BSE was predicted by different variables across age and cultural groups. 2. In particular, practice of BSE in younger women was predicted by knowledge about breast cancer, perceived barriers, health motivation and cues for action, whereas practice in older women was predicted by knowledge about BSE, perceived barriers and cues for action. 3. BSE rates in both countries were higher than previously reported but did not differ between women in Scotland and Greece. However, the two groups differed in knowledge and attitudes, regarding BSE, and in personality. Women in Scotland appeared more knowledgeable regarding BSE, felt less susceptible to breast cancer and were less active in coping with health issues than women in Greece. Women in Greece valued their health more and scored higher in chance health locus of control beliefs than women in Scotland. 4. The best predictor of breast screening mammography attendance in Scotland was knowledge about mammography. Attenders appeared to have more knowledge about breast cancer and about mammography and to focus more on emotional coping, in order to deal with health stresses. 5. The two cultural groups differed in health-related decision making and health - related coping styles. Attenders in Scotland were more knowledgeable about risk factors related to breast cancer and about mammograms and perceived significantly more pain/discomfort associated with the procedure, than attenders in Greece. Attenders in Greece resorted more to acceptance and denial and were more likely to seek emotional support, in order to cope with health stressors than attenders in Scotland. 6. Health beliefs of breast cancer patients, in relation to their condition, and their style of coping with threatening information, concerning their breast problem, are highlighted as important factors to their adjustment in both cultures. However, adjustment to breast cancer surgery appears culture-specific, as different factors seem to determine it in different cultural contexts. 7. Patients in Scotland and Greece did not differ in their overall adjustment. However, Greek patients were significantly less well adjusted sexually postoperatively than patients in Scotland. Findings are discussed in relation to theoretical and practical implications.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Mastectomie – Patientes"

1

Espérance et cancer. Éditions Le Renouveau, 1987.

APA, Harvard, Vancouver, ISO, and other styles
2

Zuckweiler, Rebecca L. Living in the postmastectomy body: Learning to live in and love your body again. Hartley & Marks, 1998.

APA, Harvard, Vancouver, ISO, and other styles
3

Why I wore lipstick to my mastectomy. St. Martin's Griffin, 2004.

APA, Harvard, Vancouver, ISO, and other styles
4

Roberts, Helen. The patient patients: Women and their doctors. Pandora Press, 1985.

APA, Harvard, Vancouver, ISO, and other styles
5

Why I wore lipstick to my mastectomy. St. Martin's Press, 2004.

APA, Harvard, Vancouver, ISO, and other styles
6

Up front: Sex and the post-mastectomy woman. Penguin Books, 1991.

APA, Harvard, Vancouver, ISO, and other styles
7

Up front: Sex and the post-mastectomy woman. Viking, 1990.

APA, Harvard, Vancouver, ISO, and other styles
8

Dvorkin, Leonore H. Why I'm glad I had breast cancer. Wildside Press, 2005.

APA, Harvard, Vancouver, ISO, and other styles
9

Dvorkin, Leonore H. Why I'm glad I had breast cancer. Wildside Press, 2005.

APA, Harvard, Vancouver, ISO, and other styles
10

Bueti, Cathy. Breastless in the city. Cleveland Clinic Press, 2006.

APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Mastectomie – Patientes"

1

Wintz, L., C. Malhouitre, D. Hequet, et al. "Élaboration d’outils informatifs innovants destinés aux patientes ayant eu une mastectomie pour cancer du sein." In Acquis et limites en sénologie / Assets and limits in breast diseases. Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0396-8_76.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Héquet, D., S. Dolbeault, K. Zarca, et al. "Facteurs décisifs de non-reconstruction chez 1 937 femmes après mastectomie totale ; information et choix des patientes." In Cancer du sein : surdiagnostic, surtraitement. Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jackson, Rubie Sue, Robert Buras, and Lorraine Tafra. "Patient Selection and Breast Imaging." In Operative Approaches to Nipple-Sparing Mastectomy. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43259-5_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tousimis, Eleni, and Lindsay Potdevin. "Nipple-Sparing Mastectomy in the Previously Radiated Patient." In Operative Approaches to Nipple-Sparing Mastectomy. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43259-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Boughey, Judy C., and Amy C. Degnim. "Prophylactic Mastectomy in Patients with Atypical Breast Lesions." In Atypical Breast Proliferative Lesions and Benign Breast Disease. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92657-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vlastos, Georges, Elisabetta Rapiti, Helena M. Verkooijen, and Christine Bouchardy. "Lumpectomy or Mastectomy in Patients Presenting with Metastatic Disease." In Breast Surgical Techniques and Interdisciplinary Management. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6076-4_83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Soran, Atilla, and Kazim Senol. "Genetic Predispositions and Prophylactic Mastectomy in Breast Cancer Patients." In Prophylactic Surgery. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-66853-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mlodinow, Alexei S., Steven T. Lanier, Robert D. Galiano, and John Y. S. Kim. "Using the Breast Reconstruction Risk Assessment (BRA) Score: An Individualized Risk Calculator to Assist Expectation Management and Reconstructive Decision Making in the Mastectomy Patient." In Operative Approaches to Nipple-Sparing Mastectomy. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43259-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Willey, Shawna C., Troy A. Pittman, and James M. Economides. "Staged Nipple-Sparing Mastectomy for Patients with Large or Ptotic Breasts." In Oncoplastic Breast Surgery Techniques for the General Surgeon. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40196-2_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Clacey, Robert, Chris Thomas, and Henry Pearson. "The Effectiveness of a Ward-Based Nurse Counselling Service for Mastectomy Patients." In Psychosomatic Medicine. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5454-3_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Mastectomie – Patientes"

1

Liew, Belle, Clea Southall, Muholan Kanapathy, and Dariush Nikkhah. "Does Post-Mastectomy Radiation Therapy Worsen Outcomes in Immediate Autologous Breast Flap Reconstruction? A Systematic Review and Meta-Analysis." In VIRTUAL ACADEMIC SURGERY CONFERENCE 2021. Cambridge Medicine Journal, 2021. http://dx.doi.org/10.7244/cmj.2021.04.001.1.

Full text
Abstract:
Background There is great uncertainty regarding the practice of immediate autologous breast reconstruction (IBR) when post-mastectomy radiotherapy (PMRT) is indicated. Many plastic surgery units differ in their protocols, with some recommending delayed breast reconstruction (DBR) instead. Nevertheless, the cosmetic and psychosocial benefits offered by IBR are significant. The aim of this study was to comprehensively review and analyse existing literature to compare irradiated and unirradiated autologous flaps. Methods A comprehensive search in MEDLINE, EMBASE and CENTRAL databases was conducted in November 2020 for primary studies assessing outcomes of IBR with and without PMRT. Primary outcomes were the incidence of clinical complications, observer- and patient-reported outcomes. Meta-analyses were performed to obtain the pooled risk ratio of individual complications where possible. Results Twenty-one articles involving 3817 patients were included. Meta-analysis of pooled data demonstrated risk ratios for fat necrosis (RR=1.91, p<0.00001), secondary surgery (RR=1.62, p=0.03) and volume loss (RR=8.16, p<0.00001) favouring unirradiated flaps, but no significant difference in all other reported complications. The unirradiated group scored higher in observer-reported outcome measures, but self-reported aesthetic and general satisfaction rates were similar. Conclusions IBR should still be offered to patients as a viable option after mastectomy, even if they require PMRT. Despite the statistically significant higher risks of fat necrosis and contracture, these changes appear to be less clinically relevant, as corroborated by generally positive self-reported scores from patients who developed the aforementioned complications. Preoperative and intraoperative measures can further optimize reconstruction and mitigate post-radiation sequelae. Careful management of patients’ expectations is also imperative.
APA, Harvard, Vancouver, ISO, and other styles
2

Balasubramanian, Priya, Archana Pradeep, Deepak Dileepkumar, John P. Farris, and Hugh Jack. "Cancer Recovery Analysis System." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-40337.

Full text
Abstract:
Breast cancer is one of the most common types of cancer among women with over 230,000 incidences diagnosed every year. A typical breast cancer surgery might include but is not limited to, biopsies, breast conservation surgery or mastectomies. Moreover, these surgeries usually cause soreness in the shoulder and arms which in turn affect the ability of the patient to perform simple everyday activities. Lymphedema, another serious side effect of these surgeries, when coupled with radiation therapy, can appear in breast cancer patients during months or even years after the treatment ends. Lymphedema is a condition in which high-protein fluid collects beneath the skin and causes swelling, redness and discomfort. This condition occurs in breast cancer patients when lymph nodes are damaged or removed during the procedures. Research suggests that early physiotherapy as well as exercises can reduce the risk of lymphedema. Monitoring the progress during these exercises can be a first step in diagnosing lymphedema. Along with better prognosis, the patients can observe the benefits of early diagnosis with insurance coverage, since most insurance companies do not cover treatments associated with advanced stages of lymphedema. The initial stretching workouts, done during recovery, target the range of motion of the shoulder that is affected by the surgery. This range of motion, determined by the severity of the surgery, improves over time. These exercises can then be used to drain the lymph nodes and help retain flexibility in the affected muscles. A monitoring device engineered to provide data about the extent of recovery would be a significant aide to both the patients and healthcare professionals. The intent of the paper is to introduce a distinctive device that monitors workouts and uses the data as a motivating factor for the patient as well as an early detection system for lymphedema. The device shows the effort that the patient has put for each workout into user friendly real time graphs. Patients and healthcare professionals can then use this data and graphs to identify problem areas in the recovery process. Preliminary tests of this device, which are presented in this paper, showed promising results in accuracy and repeatability as the device calculated and displayed graphs which were a quantified estimation of the range of motion and workout effort of the user.
APA, Harvard, Vancouver, ISO, and other styles
3

Ayoola, AG, S. Alagarsamy, J. Jaboin, and S. Rao. "Increase in mastectomies performed in patients in the community settings undergoing MRI." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-6010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bennett, Angela, Irene Mabbott, and Dawn Thompson. "OP03 Venepuncture and peripheral venous cannulation in patients post mastectomy." In Abstracts from the HEE Yorkshire and the Humber Clinical Skills and Simulation Conference, Leeds, UK, 4th July 2018. The Association for Simulated Practice in Healthcare, 2018. http://dx.doi.org/10.1136/bmjstel-2018-heeconf.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kreklau, A., L. Weydandt, S. Briest, S. Stark, and B. Aktas. "Should we perform mastectomy in case of CUP syndrome after risk-reducing mastectomy in patients with germline mutation?" In 39. Jahrestagung der Deutschen Gesellschaft für Senologie. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1688008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sagripant, A., A. Carpi, U. Baicchi, A. Nicolini, and M. Ferdeghint. "ORAL ANTICOAGULANTS IN BREAST CANCER PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643671.

Full text
Abstract:
As the fibrin clot may play a role in the intravascular metastatic spread of breast cancer, we have treated women with advanced breast cancer with oral anticoagulants. After mastectomy, 11 consentient women with postsurgical stage Nl (6 patients), N2 (3 patients) and N3 (2 patients) and without evidence of distantmetastasis have been treated with acenocoumarol (INR 2-4,5) for 4-22 months (mean 12 months). All the patients received adjuvant therapy (radiotherapy, polichemiotherapy and/or tamoxifen) in conformity with theclassic indications. FibrinopeptideA plasmatic level, checked in everyone on stable anticoagulation, was always lower than 2 ng/ml (mean 0,78 ng/ml). No major bleeding occurred, except a copious hematuria caused by overdosage. Until now all the 11 women are alive. Two of them stopped anticoagulant, one because of hemorrhagic cystitis, the other because of awareness of visceral metastases; all the other 9 women arebeing treated now. Three patients(2N2 and 1 N3) have evidence of visceral metastases; no sign of relapsehas been observed by serial instrumental and laboratory examinations inthe other 8 women. A control group of 13 patients (9 N2 and 4 N3)was compared with the group of anticoagulated patients in more advanced stages (2 N2 and 3 N3):The follow-up of the anticoagulatedNl patients is too brief as yet forcomparative evaluation. Our preliminary data seem to indicate an useful role of oral anticoagulants inbreast cancer and oblige us to prolong investigation.
APA, Harvard, Vancouver, ISO, and other styles
7

Silva, Murilo H. C., Natália S. D. Mendonça, Guilherme A. Sampaio, Laine R. Martins, Júlia de J. Caetano, and Juliana A. Sampaio. "THE IMPORTANCE OF EARLY DETECTION OF DEPRESSION IN POST-MASTECTOMY PATIENTS." In Brazilian Breast Cancer Symposium. v29s1, 2019. http://dx.doi.org/10.29289/259453942019v29s1ep34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tan, Maxine, Rudi Deklerck, An Tassenoy, Jan Cornelis, Johan de Mey, and Nico Buls. "Histogram analysis of CT scans for patients with post-mastectomy lymphedema." In 2011 18th IEEE International Conference on Image Processing (ICIP 2011). IEEE, 2011. http://dx.doi.org/10.1109/icip.2011.6115752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cobain, E., S. Hong, H. Abe, et al. "The Effect of Preoperative MRI on Mastectomy Rates in Breast Cancer Patients." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-4019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fu, Yun, Zhigang Zhuang, Michelle Dewing, Apple Sophia, and Chang R. Helena. "Abstract P2-13-13: Predictors of bilateral mastectomy in breast cancer patients." In Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-p2-13-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Mastectomie – Patientes"

1

Lowe, Elaine. Counseling needs of mastectomy patients: Reach to Recovery Program. Portland State University Library, 2000. http://dx.doi.org/10.15760/etd.2076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Saldanha, Ian J., Wangnan Cao, Justin M. Broyles, et al. Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer245.

Full text
Abstract:
Objectives. This systematic review evaluates breast reconstruction options for women after mastectomy for breast cancer (or breast cancer prophylaxis). We addressed six Key Questions (KQs): (1) implant-based reconstruction (IBR) versus autologous reconstruction (AR), (2) timing of IBR and AR in relation to chemotherapy and radiation therapy, (3) comparisons of implant materials, (4) comparisons of anatomic planes for IBR, (5) use versus nonuse of human acellular dermal matrices (ADMs) during IBR, and (6) comparisons of AR flap types. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to March 23, 2021, to identify comparative and single group studies. We extracted study data into the Systematic Review Data Repository Plus (SRDR+). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42020193183). Results. We found 8 randomized controlled trials, 83 nonrandomized comparative studies, and 69 single group studies. Risk of bias was moderate to high for most studies. KQ1: Compared with IBR, AR is probably associated with clinically better patient satisfaction with breasts and sexual well-being but comparable general quality of life and psychosocial well-being (moderate SoE, all outcomes). AR probably poses a greater risk of deep vein thrombosis or pulmonary embolism (moderate SoE), but IBR probably poses a greater risk of reconstructive failure in the long term (1.5 to 4 years) (moderate SoE) and may pose a greater risk of breast seroma (low SoE). KQ 2: Conducting IBR either before or after radiation therapy may result in comparable physical well-being, psychosocial well-being, sexual well-being, and patient satisfaction with breasts (all low SoE), and probably results in comparable risks of implant failure/loss or need for explant surgery (moderate SoE). We found no evidence addressing timing of IBR or AR in relation to chemotherapy or timing of AR in relation to radiation therapy. KQ 3: Silicone and saline implants may result in clinically comparable patient satisfaction with breasts (low SoE). There is insufficient evidence regarding double lumen implants. KQ 4: Whether the implant is placed in the prepectoral or total submuscular plane may not be associated with risk of infections that are not explicitly implant related (low SoE). There is insufficient evidence addressing the comparisons between prepectoral and partial submuscular and between partial and total submuscular planes. KQ 5: The evidence is inconsistent regarding whether human ADM use during IBR impacts physical well-being, psychosocial well-being, or satisfaction with breasts. However, ADM use probably increases the risk of implant failure/loss or need for explant surgery (moderate SoE) and may increase the risk of infections not explicitly implant related (low SoE). Whether or not ADM is used probably is associated with comparable risks of seroma and unplanned repeat surgeries for revision (moderate SoE for both), and possibly necrosis (low SoE). KQ 6: AR with either transverse rectus abdominis (TRAM) or deep inferior epigastric perforator (DIEP) flaps may result in comparable patient satisfaction with breasts (low SoE), but TRAM flaps probably increase the risk of harms to the area of flap harvest (moderate SoE). AR with either DIEP or latissimus dorsi flaps may result in comparable patient satisfaction with breasts (low SoE), but there is insufficient evidence regarding thromboembolic events and no evidence regarding other surgical complications. Conclusion. Evidence regarding surgical breast reconstruction options is largely insufficient or of only low or moderate SoE. New high-quality research is needed, especially for timing of IBR and AR in relation to chemotherapy and radiation therapy, for comparisons of implant materials, and for comparisons of anatomic planes of implant placement.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography